Generix Group announces a stake acquisition in Sologlobe Logistics Inc

Paris, September 14, 2016 - Generix Group, Industrial, Logistical and Retail Ecosystems provider with leading Collaborative Software Solutions, announces today the signing of a preliminary accord to take a majority stake in the Canadian Company Sologlobe Logistique Inc, specialized in Supply Chain solutions.

With a CAD $6 millions revenue, Sologlobe Logistics Inc is a Company specialized in Supply Chain solutions. This project of acquisition will allow to Generix Group to better support its customers in the North American continent and will contribute positively to the Group's results.

This project of a mojority stake acquisition should be finalized early October.

***

Next press release: October 31, 2016 after closing of the stock exchange
Revenue for the second quarter of the 2016/2017 fiscal year

 Contacts

Ludovic Luzza
Chief Financial Officer
Tel.: +33 (0)1 77 45 42 80
lluzza@generixgroup.com
www.generixgroup.com

 
Stéphanie Stahr
CM-CIC Market Solutions
Tel.: +33 (0)1 45 96 77 83
stephanie.stahr@cmcic.com
www.cmcicms.com
 

About Generix Group

Software editor of collaborative applications, Generix Group helps its customers to face digital enterprise challenges: facilitating buying journeys, building a digital supply chain, and dematerializing all data flows. By building differentiating services, Generix Group optimizes the overall performance of the company within its ecosystem, enabling it to meet customers' new expectations.

Over 5,000 international players have contributed to establishing Generix Group as a European leader, with close to €58 million in turnover

For more information, visit www.generixgroup.com




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Generix Group via Globenewswire

Source(s) : Generix Group